Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Vivencio Barrios & Carlos Escobar. (2013)
Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?. Expert Opinion on Pharmacotherapy 14:16, pages 2249-2261.
Read now
Read now
LM Ruilope & Helmut Schumacher. (2012) Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertension. Expert Opinion on Pharmacotherapy 13:16, pages 2417-2425.
Read now
Read now
Articles from other publishers (18)
Rawan O. Almadfaa, Patricia R. Wigle, Ana L. Hincapie & Jeff J. Guo. (2023) The Utilization, Expenditure, and Price of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the US Medicaid Programs: Trends Over a 31 Year Period. International Journal of Cardiology 370, pages 412-418.
Crossref
Crossref
Maria Greabu, Silviu Constantin Badoiu, Iulia-Ioana Stanescu-Spinu, Daniela Miricescu, Alexandra Ripszky Totan, Silvia Elena Badoiu, Michel Costagliola & Viorel Jinga. (2021) Drugs Interfering with Insulin Resistance and Their Influence on the Associated Hypermetabolic State in Severe Burns: A Narrative Review. International Journal of Molecular Sciences 22:18, pages 9782.
Crossref
Crossref
Ming-Chi Lai, Sheng-Nan Wu & Chin-Wei Huang. (2020) Telmisartan, an Antagonist of Angiotensin II Receptors, Accentuates Voltage-Gated Na+ Currents and Hippocampal Neuronal Excitability. Frontiers in Neuroscience 14.
Crossref
Crossref
Yogesh Murti, Devender Pathak & Kamla Pathak. 2020. Applications of Nanotechnology for Green Synthesis. Applications of Nanotechnology for Green Synthesis
191
222
.
Saro H Armenian, Christopher J Gibson, Russell C Rockne & Kirsten K Ness. (2019) Premature Aging in Young Cancer Survivors. JNCI: Journal of the National Cancer Institute 111:3, pages 226-232.
Crossref
Crossref
Wei-Ting Chang & Sheng-Nan Wu. (2018)
Activation of voltage-gated sodium current and inhibition of
erg
-mediated potassium current caused by telmisartan, an antagonist of angiotensin II type-1 receptor, in HL-1 atrial cardiomyocytes
. Clinical and Experimental Pharmacology and Physiology 45:8, pages 797-807.
Crossref
Crossref
Edmund Cheung So, Sheng-Nan Wu, Yi-Ching Lo & Kevin Su. (2018) Differential regulation of tefluthrin and telmisartan on the gating charges of I Na activation and inactivation as well as on resurgent and persistent I Na in a pituitary cell line (GH 3 ). Toxicology Letters 285, pages 104-112.
Crossref
Crossref
O A Kislyak & Yu B Chervyakova. (2015) «New» molecules composed of rational combinations of antihypertensive drugs: issues of choice. Systemic Hypertension 12:4, pages 42-45.
Crossref
Crossref
Shu-Chen Chien, Shuo-Ming Ou, Chia-Jen Shih, Pei-Wen Chao, Szu-Yuan Li, Yi-Jung Lee, Shu-Chen Kuo, Shuu-Jiun Wang, Tzeng-Ji Chen, Der-Cherng Tarng, Hsi Chu & Yung-Tai Chen. (2015) Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Terms of Major Cardiovascular Disease Outcomes in Elderly Patients. Medicine 94:43, pages e1751.
Crossref
Crossref
Krzysztof Łukawski, Grzegorz Raszewski & Stanisław J. Czuczwar. (2014) Interactions between levetiracetam and cardiovascular drugs against electroconvulsions in mice. Pharmacological Reports 66:6, pages 1100-1105.
Crossref
Crossref
Gabriel Faria-Costa, Adelino Leite-Moreira & Tiago Henriques-Coelho. (2014) Cardiovascular effects of the angiotensin type 2 receptor. Revista Portuguesa de Cardiologia (English Edition) 33:7-8, pages 439-449.
Crossref
Crossref
Gabriel Faria-Costa, Adelino Leite‐Moreira & Tiago Henriques‐Coelho. (2014) Efeitos cardiovasculares do receptor tipo 2 da angiotensina. Revista Portuguesa de Cardiologia 33:7-8, pages 439-449.
Crossref
Crossref
Krzysztof Łukawski, Agnieszka Janowska, Tomasz Jakubus & Stanisław J. Czuczwar. (2014)
Interactions between angiotensin AT
1
receptor antagonists and second-generation antiepileptic drugs in the test of maximal electroshock
. Fundamental & Clinical Pharmacology 28:3, pages 277-283.
Crossref
Crossref
Axel C Carlsson, Per Wändell, Kristina Sundquist, Sven-Erik Johansson & Jan Sundquist. (2014) Effects of prescribed antihypertensives and other cardiovascular drugs on mortality in patients with atrial fibrillation and hypertension: a cohort study from Sweden. Hypertension Research 37:6, pages 553-559.
Crossref
Crossref
Jou-Wei LinChia-Hsuin ChangJames L. CaffreyLi-Chiu WuMei-Shu Lai. (2014) Examining the Association of Olmesartan and Other Angiotensin Receptor Blockers With Overall and Cause-Specific Mortality. Hypertension 63:5, pages 968-976.
Crossref
Crossref
Krzysztof Łukawski, Agnieszka Janowska, Tomasz Jakubus, Grzegorz Raszewski & Stanisław J. Czuczwar. (2013) Combined treatment with gabapentin and drugs affecting the renin–angiotensin system against electroconvulsions in mice. European Journal of Pharmacology 706:1-3, pages 92-97.
Crossref
Crossref
Sonia Zambrano, Antonio J. Blanca, María V. Ruiz-Armenta, José L. Miguel-Carrasco, Miguel Arévalo, María J. Vázquez, Alfonso Mate & Carmen M. Vázquez. (2013) l-Carnitine protects against arterial hypertension-related cardiac fibrosis through modulation of PPAR-γ expression. Biochemical Pharmacology 85:7, pages 937-944.
Crossref
Crossref
Juan M. Saavedra. (2012) Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders. Clinical Science 123:10, pages 567-590.
Crossref
Crossref